Medroxyprogesterone Acetate Injection, Suspension
NDC Package 70518-4324-0

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Medroxyprogesterone Acetate injection is a medication used to prevent pregnancy. This formulation utilizes a injection, suspension delivery system. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-4324 and is authorized under FDA application ANDA215397.

Identification & Billing

NDC Package Code
70518-4324-0
Package Description
1 SYRINGE, GLASS in 1 CARTON / 1 mL in 1 SYRINGE, GLASS
Product Code
70518-4324
11-Digit Billing Format
70518432400
RxNorm Crosswalk
  • RxCUI: 1000153 - medroxyPROGESTERone acetate 150 MG in 1 ML Prefilled Syringe
  • RxCUI: 1000153 - 1 ML medroxyprogesterone acetate 150 MG/ML Prefilled Syringe
  • RxCUI: 1000153 - medroxyprogesterone acetate 150 MG per 1 ML Prefilled Syringe

Clinical Specifications

Proprietary Name
Medroxyprogesterone Acetate
Non-Proprietary Name
Medroxyprogesterone Acetate
Substance Name
Medroxyprogesterone Acetate
Dosage Form
Injection, Suspension - A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa.
Administration Route
Intramuscular - Administration within a muscle.
Active Ingredient(s)
MEDROXYPROGESTERONE ACETATE 150 mg/mL
Pharmacologic Class
Usage Information
This medication is used to prevent pregnancy. Medroxyprogesterone is like a natural hormone made by the body. It works mainly by preventing the growth and release of an egg (ovulation) during your menstrual cycle. It also makes vaginal fluid thicker to help prevent sperm from reaching an egg (fertilization) and changes the lining of the uterus (womb) to prevent attachment of a fertilized egg. Medroxyprogesterone is also used to treat endometriosis. It works by lowering the amount of certain hormones in the body and decreasing the growth of abnormal tissues that cause endometriosis. This helps reduce pain and other symptoms. Using this medication does not protect you or your partner against sexually transmitted diseases (such as HIV, gonorrhea, chlamydia).

Regulatory & Marketing

Labeler Name
Remedyrepack Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA215397
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
04-01-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70518-4324-0 identifies a specific commercial package of 1 syringe, glass in 1 carton / 1 ml in 1 syringe, glass of Medroxyprogesterone Acetate, a human prescription drug labeled by Remedyrepack Inc.. This injection, suspension is formulated for intramuscular use and contains medroxyprogesterone acetate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Remedyrepack Inc. on April 01, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to prevent pregnancy. Medroxyprogesterone is like a natural hormone made by the body. It works mainly by preventing the growth and release of an egg (ovulation) during your menstrual cycle. It also makes vaginal fluid thicker to help prevent sperm from reaching an egg (fertilization) and changes the lining of the uterus (womb) to prevent attachment of a fertilized egg. Medroxyprogesterone is also used to treat endometriosis. It works by lowering the amount of certain hormones in the body and decreasing the growth of abnormal tissues that cause endometriosis. This helps reduce pain and other symptoms. Using this medication does not protect you or your partner against sexually transmitted diseases (such as HIV, gonorrhea, chlamydia).

How is this Remedyrepack Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518432400. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70518-4324-0
11-Digit CMS (5-4-2)
70518-4324-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.